Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2014. The report serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by several executives on January 10, 2014, executed through the Company's ShareReward Plan. The transactions occurred at a price of 1606.55 pence per share. The changes include:
- Sir Andrew Witty: Acquired 8 shares (personal) and 8 shares (company match).
- Mr S Dingemans: Acquired 8 shares (personal) and 8 shares (company match).
- Mr S M Bicknell: Acquired 8 shares (personal) and 8 shares (company match).
- Mr R G Connor: Acquired 8 shares (personal) and 8 shares (company match).
- Mr D S Redfern: Acquired 8 shares (personal) and 8 shares (company match).
- Ms C Thomas: Acquired 8 shares (personal) and 8 shares (company match).
- Mr P C Thomson: Acquired 7 shares (personal) and 7 shares (company match).
- Dr P J T Vallance: Acquired 8 shares (personal) and 8 shares (company match).
- Ms E Walmsley: Acquired 8 shares (personal) and 8 shares (company match).
- Mrs V A Whyte: Acquired 8 shares (personal) and 8 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of share purchases in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Checklist
- Verify the share price of 1606.55 pence against market data for January 10, 2014.
- Confirm the total number of shares acquired by each listed executive to ensure alignment with the ShareReward Plan rules.
- Review the company's annual report (Form 20-F) for comprehensive financial metrics, as this 6-K does not contain them.